World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal

about

World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal

Item

http://www.wikidata.org/entity/Q56334878

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

World hepatitis day in Burkina ...... ieve the 2030 elimination goal

@en

World hepatitis day in Burkina ...... ieve the 2030 elimination goal

@nl

type

Item

label

World hepatitis day in Burkina ...... ieve the 2030 elimination goal

@en

World hepatitis day in Burkina ...... ieve the 2030 elimination goal

@nl

prefLabel

World hepatitis day in Burkina ...... ieve the 2030 elimination goal

@en

World hepatitis day in Burkina ...... ieve the 2030 elimination goal

@nl

P1476

World hepatitis day in Burkina ...... ieve the 2030 elimination goal

@en

P2093

Alain Bougouma

http://www.w3.org/2001/XMLSchema#string

Albert Theophane Yonli

http://www.w3.org/2001/XMLSchema#string

Birama Diarra

http://www.w3.org/2001/XMLSchema#string

Christelle Nadembega

http://www.w3.org/2001/XMLSchema#string

Dorcas Obiri-Yeboah

http://www.w3.org/2001/XMLSchema#string

Justine Yara

http://www.w3.org/2001/XMLSchema#string

Paul Ouedraogo

http://www.w3.org/2001/XMLSchema#string

Rokia Sanogo

http://www.w3.org/2001/XMLSchema#string

Theodora Mahoukèdè Zohoncon

http://www.w3.org/2001/XMLSchema#string

P2860

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

Seroepidemiology of hepatitis B and C viruses in the general population of burkina faso.

Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis among blood donors in Koudougou (Burkina Faso) in 2009

High hepatitis B virus load is associated with hepatocellular carcinomas development in Chinese chronic hepatitis B patients: a case control study.

Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched.

Screening of Hepatitis G and Epstein-Barr Viruses Among Voluntary non Remunerated Blood Donors (VNRBD) in Burkina Faso, West Africa

Prevalence and molecular diversity of hepatitis B virus and hepatitis delta virus in urban and rural populations in northern Gabon in central Africa.

Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis.

Point-of-care screening for hepatitis B virus infection in pregnant women at an antenatal clinic: A South African experience.

Prevalence of infection by HHV-8, HIV, HCV and HBV among pregnant women in Burkina Faso.

P2888

s12985-018-1032-5

P304

121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12985-018-1032-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jacques Simpore

Abdoul Karim Ouattara

Lassina Traore

Virginio Pietra

P577

2018-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106015522

http://www.w3.org/2001/XMLSchema#string

P698

30081915

http://www.w3.org/2001/XMLSchema#string

P921

Seroprevalence

virology

Burkina Faso

P932

6080359

http://www.w3.org/2001/XMLSchema#string